| Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations RR Edwards, RH Dworkin, DC Turk, MS Angst, R Dionne, R Freeman, ... Pain Reports 6 (1), e896, 2021 | 366 | 2021 |
| Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial IR Kleckner, C Kamen, JS Gewandter, NA Mohile, CE Heckler, ... Supportive Care in Cancer 26, 1019-1028, 2018 | 304 | 2018 |
| The ACTTION-American Pain Society Pain Taxonomy (AAPT): an evidence-based and multidimensional approach to classifying chronic pain conditions RB Fillingim, S Bruehl, RH Dworkin, SF Dworkin, JD Loeser, DC Turk, ... The Journal of Pain 15 (3), 241-249, 2014 | 238 | 2014 |
| Assessment of physical function and participation in chronic pain clinical trials: IMMPACT/OMERACT recommendations AM Taylor, K Phillips, KV Patel, DC Turk, RH Dworkin, D Beaton, ... Pain 157 (9), 1836-1850, 2016 | 194 | 2016 |
| Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study JS Gewandter, L Fan, A Magnuson, K Mustian, L Peppone, C Heckler, ... Supportive care in cancer 21, 2059-2066, 2013 | 187 | 2013 |
| Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations JS Gewandter, RH Dworkin, DC Turk, JT Farrar, RB Fillingim, I Gilron, ... Pain 156 (7), 1184-1197, 2015 | 157 | 2015 |
| Thapsigargin induces biphasic fragmentation of mitochondria through calcium‐mediated mitochondrial fission and apoptosis JR Hom, JS Gewandter, L Michael, SS Sheu, Y Yoon Journal of cellular physiology 212 (2), 498-508, 2007 | 156 | 2007 |
| A phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP … JS Gewandter, SG Mohile, CE Heckler, JL Ryan, JJ Kirshner, PJ Flynn, ... Supportive Care in Cancer 22, 1807-1814, 2014 | 143 | 2014 |
| The ACTTION–APS–AAPM Pain Taxonomy (AAAPT) multidimensional approach to classifying acute pain conditions ML Kent, PJ Tighe, I Belfer, TJ Brennan, S Bruehl, CM Brummett, ... Pain Medicine 18 (5), 947-958, 2017 | 127 | 2017 |
| Cancer‐related stress and complementary and alternative medicine: a review KD Chandwani, JL Ryan, LJ Peppone, MM Janelsins, LK Sprod, K Devine, ... Evidence‐Based Complementary and Alternative Medicine 2012 (1), 979213, 2012 | 95 | 2012 |
| The effect of YOCAS©® yoga for musculoskeletal symptoms among breast cancer survivors on hormonal therapy LJ Peppone, MC Janelsins, C Kamen, SG Mohile, LK Sprod, ... Breast cancer research and treatment 150, 597-604, 2015 | 92 | 2015 |
| Ensuring transparency and minimization of methodologic bias in preclinical pain research: PPRECISE considerations NA Andrews, A Latrémolière, AI Basbaum, JS Mogil, F Porreca, ASC Rice, ... Pain 157 (4), 901-909, 2016 | 84 | 2016 |
| Trial designs for chemotherapy-induced peripheral neuropathy prevention: ACTTION recommendations JS Gewandter, J Brell, G Cavaletti, PM Dougherty, S Evans, L Howie, ... Neurology 91 (9), 403-413, 2018 | 78 | 2018 |
| Overview and critical revision of clinical assessment tools in chemotherapy‐induced peripheral neurotoxicity SB Park, P Alberti, NA Kolb, JS Gewandter, A Schenone, AA Argyriou Journal of the Peripheral Nervous System 24, S13-S25, 2019 | 76 | 2019 |
| Idiopathic distal sensory polyneuropathy: ACTTION diagnostic criteria R Freeman, JS Gewandter, CG Faber, C Gibbons, S Haroutounian, ... Neurology 95 (22), 1005-1014, 2020 | 61 | 2020 |
| Oral curcumin for radiation dermatitis: A URCC NCORP study of 686 breast cancer patients J Ryan Wolf, CE Heckler, JJ Guido, AR Peoples, JS Gewandter, M Ling, ... Supportive Care in Cancer 26, 1543-1552, 2018 | 59 | 2018 |
| Double-blind, randomized, controlled, crossover trial of pregabalin for neurogenic claudication JD Markman, ME Frazer, SA Rast, MP McDermott, JS Gewandter, ... Neurology 84 (3), 265-272, 2015 | 53 | 2015 |
| Pain intensity rating training: results from an exploratory study of the ACTTION PROTECCT system SM Smith, D Amtmann, RL Askew, JS Gewandter, M Hunsinger, ... Pain 157 (5), 1056-1064, 2016 | 52 | 2016 |
| Chemotherapy-induced peripheral neuropathy (CIPN) and its treatment: an NIH Collaboratory study of claims data JS Gewandter, AS Kleckner, JH Marshall, JS Brown, LH Curtis, J Bautista, ... Supportive Care in Cancer 28, 2553-2562, 2020 | 51 | 2020 |
| Wireless transcutaneous electrical nerve stimulation device for chemotherapy-induced peripheral neuropathy: an open-label feasibility study JS Gewandter, J Chaudari, C Ibegbu, R Kitt, J Serventi, J Burke, ... Supportive Care in Cancer 27, 1765-1774, 2019 | 49 | 2019 |
